Odanacatib, a Cathepsin-K Inhibitor for Osteoporosis: A Two-Year Study in Postmenopausal Women With Low Bone Density

Henry G. Bone*, Michael R. McClung, Christian Roux, Robert R. Recker, John A. Eisman, Nadia Verbruggen, Carolyn M. Hustad, Carolyn DaSilva, Arthur C. Santora, B. Avery Ince

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Odanacatib, a Cathepsin-K Inhibitor for Osteoporosis: A Two-Year Study in Postmenopausal Women With Low Bone Density'. Together they form a unique fingerprint.

Keyphrases

INIS

Pharmacology, Toxicology and Pharmaceutical Science